1.Anisimov VN, Sikora E, Pawelec G. Relationships between cancer and aging: a multilevel approach. Biogerontology. 2009;10(4):323-338.

2.Boiron JM, Dazey B, Cailliot C, et al. Large-s easy informative essay topics good debate topics cale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion, 2006; 46: 1934-1942.

3.Boyette, L.B. and R.S. Tuan, Adult Stem Cells and Diseases easy informative essay topics good debate topics of Aging. J Clin Med, 2014. 3(1): p. 88-134.

4.Burt RK, Traynor A, Statkute L, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. Jama. 2006;295(5):527-535.

5.Candore G, Colonna-Romano G, Balistreri CR, et al. Biology of longevity: role of the innate immune system. Rejuvenation Res. 2006;9(1):143-148.

6.Charron D. Autologous white blood cell transfusion: toward a younger immunity. Hum.Immunol. 2007;68(10):805-812.

7.Chen SH, Wang TF, Yang KL. Hematopoietic stem cell donation. International journal of hematology. 2013;97(4):446-455.

8.Chinn IK, Blackburn CC, Manley NR, Sempowski GD. Changes in primary lymphoid organs with aging. Semin.Immunol. 2012;24(5):309-320.

9.Conboy IM, Conboy MJ, Rebo J. Systemic Problems: A perspective on stem cell aging and rejuvenation. Aging (Albany NY). 2015;7(10):754-765.

10.Copelan EA. Hematopoietic stem-cell transplantation. The New England journal of medicine. 2006;354(17):1813-1826. Kleer I, Vastert B, Klein M, et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood. 2006;107(4):1696-1702. Pooter RF, Cho SK, Carlyle JR, Zuniga-Pflucker JC. In vitro generation of T lymphocytes from embryonic stem cell-derived prehematopoietic progenitors. Blood. 2003;102(5):1649-1653.

13.Donmez A, Arik B, Tombuloglu M, Cagirgan S. Risk factors for adverse events during collection of peripheral blood stem cells. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2011;45(1):13-16.

14.Farge D, Labopin M, Tyndall A, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica. 2010;95(2):284-292.

15.Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations. International journal of cardiology. 2012.

16.Fontana L, Partridge L, and Longo VD. Extending healthy life span-from yeast to humans. Science, 2010. 328(5976): p. 321-6.

17.Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128(1):92-105.

18.Franceschi C. Inflammaging as a major characteristic of old people: Can it be prevented or cured? Nutrition reviews. 2007;65(12):S173-S176.

19.Frasca D, Blomberg BB. Effects of aging on B cell function. Curr Opin Immunol. 2009;21(4):425-430.

20.Fulop T, Larbi A, Kotb R, Pawelec G. Immunology of aging and cancer development 43. Interdiscip. Top. Gerontol. 2013;38:38-48.

21.Ginaldi L, De MM, Monti D, Franceschi C. The immune system in the elderly: activation-induced and damage-induced apoptosis. Immunol.Res. 2004;30(1):81-94.

22.Global Health and Aging [Internet].

23.Golpanian S, DiFede DL, Khan A., e tal. Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty. J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1505-1512.

24.Gomez CR, Boehmer ED, Kovacs EJ. The aging innate immune system. Curr Opin Immunol. 2005; 17:457–462.

25.Goodell MA, Rando TA. Stem cells and healthy aging. Science. 2015;350(6265):1199-1204.

26.Gupta S. Role of dendritic cells in innate and adaptive immune response in human aging. Exp Gerontol. 2014;54:47-52.

27.Gyurkocza B, Rezvani A, Storb RF. Allogeneic hematopoietic cell transplantation: the state of the art. Expert review of hematology. 2010;3(3):285-299.

28.Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685-1695.

29.Heron M. Deaths: Leading causes for 2011. National vital statistics reports; vol 64 no 7. Hyattsville, MD: National Center for Health Statistics. 2015.   Accessed May 31st 2016.

30.High KP. Infection as a cause of age-related morbidity and mortality. Ageing research reviews. 2004;3(1):1-14.

31.Hölig K. G-CSF in Healthy Allogeneic Stem Cell Donors. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie. 2013;40(4):225-235.

32.Ivanovic Z, Duchez P, Dazey B, et al. A clinical-scale expansion of mobilized CD34+ hematopoietic stem and progenitor cells by use of a new serum-free medium. Transfusion 2006;46:126-31.

33.Snowden J et al. – for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE).  Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases. Blood Advances 2017 1:2742-2755.

34.Kelsey PJ, Oliveira M-C, Badoglio M, Sharrack B, Farge D, Snowden JA. Haematopoietic stem cell transplantation in autoimmune diseases: from basic science to clinical practice. Curr Res Transl Med. 2016;64(2):71-82.

35.Kenyon, C.J., The genetics of ageing. Nature, 2010. 464(7288): p. 504-12.

36.Khan M, Mohsin S, Khan SN, Riazuddin S. Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice. J.Cell Mol.Med. 2011;15(7):1515-1527.

37.Kuilman T, Michaloglou C, Mooi WJ, Peeper DS.The essence of senescence. Genes Dev. 2010 Nov 15; 24(22):2463-79.

38.Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelec G. Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda, Md.). 2008;23:64-74.

39.Lazuardi L, Jenewein B, Wolf AM, Pfister G, Tzankov A, Grubeck-Loebenstein B. Age-related loss of naive T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology. 2005;114(1):37-43.

40.Licastro F, Candore G, Lio D, Porcellini E, Colonna-romano G, Franceschi C, et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. 2005;14:1–14.

41.Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M. Neutrophil ageing and immunesenescence. Mechanisms of ageing and development. 2001;122(14):1521-1535.

42.Moalic V. Mobilization and collection of peripheral blood stem cells in healthy donors: risks, adverse events and follow-up. Pathologie-biologie. 2013;61(2):70-74.

43.Pamphilon D, Siddiq S, Brunskill S, et al. Stem cell donation–what advice can be given to the donor? British journal of haematology. 2009;147(1):71-76.

44.Passweg JR, Baldomero H, Bregni M, et al. Hematopoietic SCT in Europe: data and trends in 2011 4. Bone Marrow Transplant. 2013;48(9):1161-1167.

45.Pawelec G, Goldeck D, Derhovanessian E. Inflammation, ageing and chronic disease. Curr Opin Immunol. 2014;29:23-28.

46.Pawelec G, Koch S, Griesemann H, Rehbein A, Hahnel K, Gouttefangeas C. Immunosenescence, suppression and tumour progression. Cancer immunology, immunotherapy : CII. 2006;55(8):981-986.

47.Perrine Guillaume-Jugnot, Zora Marjanovic, Myriam Labopin, et al.  Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Severe Auto-Immune Disease Adult Patients: Analysis of Outcomes from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGMT-TC) in Light of the European Society for Blood and Marrow Transplantation (EBMT) Activity. Blood 2015 126:1985;

48.Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ. Aging and innate immune cells. J Leukoc Biol. 2004; 76:291–299.

49.Potter JM, O’Donnel B, Carman WF, Roberts MA, Stott DJ. Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care. Age and ageing. 1999;28(2):141-145.

50.Rosen O, Thiel A, Massenkeil G, et al. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis research. 2000;2(4):327-336.

51.Sansoni P, Vescovini R, Fagnoni F, et al. The immune system in extreme longevity. Experimental gerontology. 2008;43(2):61-65.

52.Scudellari M. Ageing research: Blood to blood. Nature. 2015;517(7535):426-429.

53.Sharpless NE, Schatten G. Stem cell aging. J.Gerontol.A Biol.Sci.Med.Sci. 2009;64(2):202-204.

54.Shen J, Tsai YT, Dimarco NM, Long MA, Sun X, Tang L. Transplantation of mesenchymal stem cells from young donors delays aging in mice. Sci.Rep. 2011;1:67.

55.Snowden JA, Saccardi R, Allez M, et al.;EBMT Autoimmune Disease Working Party (ADWP); Paediatric Diseases Working Party (PDWP).Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2012;47(6):770-790.

56.Solana R, Pawelec G, Tarazona R. Aging and innate immunity. Immunity. 2006;24(5):491-494.

57.Thomas ED. A history of haemopoietic cell transplantation. British journal of haematology. 1999;105(2):330-339.

58.Toubert A. Immune reconstitution after allogeneic HSCT. In: Apperley J, Carreras E, Gluckman E, Massszi T, eds. The EBMT Handbook 6th Edition. Haemopoietic Stem Cell Transplantation.: ESH & EBMT; 2012.

59.Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 1997;19(7):643-645. Weng NP, Akbar AN, Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol. 2009;30(7):306-312.

60.Winkler IG, Levesque JP. Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone. Exp Hematol. 2006;34(8):996-1009.

61.Wong C, Goldstein DR. Impact of aging on antigen presentation cell function of dendritic cells. Curr Opin Immunol. 2013;25(4):535-541.

62.Woollard KJ. Immunological aspects of atherosclerosis. Clin Sci. 2013;125(5):221-235.

63.Takahashi, K.; Yamanaka, S. (2006). “Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors”. Cell. 126 (4): 663–76. doi:10.1016/j.cell.2006.07.024. PMID 16904174.

64.Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. (2007). “Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors”. Cell. 131 (5): 861–872. doi:10.1016/j.cell.2007.11.019. PMID 18035408.

65.Takahashi, K., Yamanaka, S., 2013. Induced pluripotent stem cells in medicine and biology. Development 140, 2457-2461.

66.ADEGBOLA, A., BURY, L. A., FU, C., ZHANG, M. & WYNSHAW-BORIS, A. 2017. Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases. Stem Cells Transl Med., 6, 2062-2070. doi: 10.1002/sctm.17-0150. Epub 2017 Oct 13.

67.AGUAYO-MAZZUCATO, C. & BONNER-WEIR, S. 2017. Pancreatic beta Cell Regeneration as a Possible Therapy for Diabetes. Cell Metab, 007.

68.BHARTIYA, D. 2017. Pluripotent Stem Cells in Adult Tissues: Struggling To Be Acknowledged Over Two Decades. Stem Cell Rev., 13, 713-724. doi: 10.1007/s12015-017-9756-y.

69.BHARTIYA, D., ANAND, S., PATEL, H. & PARTE, S. 2017. Making gametes from alternate sources of stem cells: past, present and future. Reprod Biol Endocrinol., 15, 89. doi: 10.1186/s12958-017-0308-8.

70.BRACHA, P., MOORE, N. A. & CIULLA, T. A. 2017. Induced pluripotent stem cell-based therapy for age-related macular degeneration. Expert Opin Biol Ther., 17, 1113-1126. doi: 10.1080/14712598.2017.1346079. Epub 2017 Jun 30.

71.BRITO, A., RUSSO, F. B., MUOTRI, A. R. & BELTRAO-BRAGA, P. C. B. 2018. Autism spectrum disorders and disease modeling using stem cells. Cell Tissue Res., 371, 153-160. doi: 10.1007/s00441-017-2685-x. Epub 2017 Sep 16.

72.CHOI, K. A., CHOI, Y. & HONG, S. 2017. Stem cell transplantation for Huntington’s diseases. Methods, 017.

73.CHRISTENSEN, C. L. & CHOY, F. Y. M. 2017. A Prospective Treatment Option for Lysosomal Storage Diseases: CRISPR/Cas9 Gene Editing Technology for Mutation Correction in Induced Pluripotent Stem Cells. Diseases., 5(1). diseases5010006. doi: 10.3390/diseases5010006.

74.CHUANG, K., FIELDS, M. A. & DEL PRIORE, L. V. 2017. Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases. Yale J Biol Med., 90, 635-642. eCollection 2017 Dec.

75.COMPAGNUCCI, C. & BERTINI, E. 2017. The Potential of iPSCs for the Treatment of Premature Aging Disorders. Int J Mol Sci., 18(11). ijms18112350. doi: 10.3390/ijms18112350.

76.DHIVYA, V. & BALACHANDAR, V. 2017. Cell replacement therapy is the remedial solution for treating Parkinson’s disease. Stem Cell Investig., 4:59., 10.21037/sci.2017.06.08. eCollection 2017.

77.GEE, P., XU, H. & HOTTA, A. 2017. Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy. Stem Cells Int, 2017:8765154., 10.1155/2017/8765154. Epub 2017 May 15.

78.GHIROLDI, A., PICCOLI, M., CICONTE, G., PAPPONE, C. & ANASTASIA, L. 2017. Regenerating the human heart: direct reprogramming strategies and their current limitations. Basic Res Cardiol., 112, 68. doi: 10.1007/s00395-017-0655-9.

79.HARRISON, P. T., HOPPE, N. & MARTIN, U. 2017. Gene editing & stem cells. J Cyst Fibros, 018.

80.KONDO, Y., TOYODA, T., INAGAKI, N. & OSAFUNE, K. 2017. iPSC technology-based regenerative therapy for diabetes. J Diabetes Investig, 12702.

81.LEBERFINGER, A. N., RAVNIC, D. J., DHAWAN, A. & OZBOLAT, I. T. 2017. Concise Review: Bioprinting of Stem Cells for Transplantable Tissue Fabrication. Stem Cells Transl Med., 6, 1940-1948. doi: 10.1002/sctm.17-0148. Epub 2017 Aug 24.

82.LINDA, K., FIUZA, C. & NADIF KASRI, N. 2017. The promise of induced pluripotent stem cells for neurodevelopmental disorders. Prog Neuropsychopharmacol Biol Psychiatry, 009.

83.MAGUIRE, E. M., XIAO, Q. & XU, Q. 2017. Differentiation and Application of Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells. Arterioscler Thromb Vasc Biol., 37, 2026-2037. doi: 10.1161/ATVBAHA.117.309196. Epub 2017 Aug 31.

84.MCKINNEY, C. E. 2017. Using induced pluripotent stem cells derived neurons to model brain diseases. Neural Regen Res., 12, 1062-1067. doi: 10.4103/1673-5374.211180.

85.MIYAGOE-SUZUKI, Y. & TAKEDA, S. 2017. Skeletal muscle generated from induced pluripotent stem cells – induction and application. World J Stem Cells., 9, 89-97. doi: 10.4252/wjsc.v9.i6.89.

86.NAGOSHI, N. & OKANO, H. 2017. iPSC-derived neural precursor cells: potential for cell transplantation therapy in spinal cord injury. Cell Mol Life Sci, 2676-9.

87.ONG, C. S., YESANTHARAO, P., HUANG, C. Y., MATTSON, G., BOKTOR, J., FUKUNISHI, T., ZHANG, H. & HIBINO, N. 2017. 3D bioprinting using stem cells. Pediatr Res, 252.

88.TAKATA, N. & EIRAKU, M. 2017. Stem cells and genome editing: approaches to tissue regeneration and regenerative medicine. J Hum Genet, 0348-0.

89.TIPANEE, J., CHAI, Y. C., VANDENDRIESSCHE, T. & CHUAH, M. K. 2017. Preclinical and clinical advances in transposon-based gene therapy. Biosci Rep., 37(6). BSR20160614. doi: 10.1042/BSR20160614. Print 2017 Dec 22.

90.TONG, G., IZQUIERDO, P. & RAASHID, R. A. 2017. Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer’s Disease: The Human Brain Outside the Dish. Open Neurol J., 11:27-38., 10.2174/1874205X01711010027. eCollection 2017.

91.WAHLESTEDT, M. & BRYDER, D. 2017. The slippery slope of hematopoietic stem cell aging. Exp Hematol., 56:1-6., 10.1016/j.exphem.2017.09.008. Epub 2017 Sep 21.

92.WEED, L. S. & MILLS, J. A. 2017. Strategies for retinal cell generation from human pluripotent stem cells. Stem Cell Investig., 4:65., 10.21037/sci.2017.07.02. eCollection 2017.

93.YOSHIDA, Y. & YAMANAKA, S. 2017. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications. Circ Res., 120, 1958-1968. doi: 10.1161/CIRCRESAHA.117.311080.

Kontaktirajte nas in se nam pridružite na BREZPLAČNI predstavitvi